Transdermal delivery of cyclosporin-A using electroporation

被引:56
|
作者
Wang, S [1 ]
Kara, M [1 ]
Krishman, TR [1 ]
机构
[1] Mem Univ Newfoundland, Sch Pharm, St John, NF A1B 3V6, Canada
关键词
electroporation; ethanol; transdermal delivery; cyclosporin A;
D O I
10.1016/S0168-3659(97)00117-X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Topical delivery of cyclosporin A (CSA) is desirable for treating psoriasis, but it is hindered by the barrier property of stratum corneum, and the physicochemical properties of CSA. Attempts to deliver CSA from a solution prepared in 40% ethanol (EtOH) in phosphate buffered saline (PBS) using iontophoresis did not result in any significant increase in drug delivery, compared to passive. However, the use of electroporation pulses as a physical penetration enhancer enabled delivery of a significant amount of CSA. Single pulse electroporation study indicated that the amount of EtOH delivered across the skin increased as the applied electrode voltage (U-electrode) was increased. However, it did not translate into a proportional increase in the delivery of CSA and only a three to four times increase, compared to passive delivery, was seen with the single pulse electroporation. The drug contact duration had a varying effect in the efficiency of transdermal delivery of CSA. Four hour contact duration was chosen for the multiple pulse study. Use of multiple pulses (25 pulses, 10 ms each) at U-electrode 200 V resulted in a sixty-fold increase, compared to passive, in the delivery of CSA to the skin. Transdermally delivered CSA was mostly bound to the skin and only a small amount was seen to cross the full skin into the receiver compartment. In a study of solvent transport, the flux of water was up to three times larger than that of EtOH after electroporation. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 50 条
  • [41] CYCLOSPORIN-A IN OPHTHALMOLOGY
    RADDA, TM
    GNAD, HD
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1984, 185 (05) : 441 - 443
  • [42] NEPHROTOXICITY OF CYCLOSPORIN-A
    WHITING, PH
    BLAIR, JT
    SIMPSON, JG
    DAVIDSON, RJL
    THOMSON, AW
    LANCET, 1981, 1 (8221): : 663 - 664
  • [43] CYCLOSPORIN-A NEPHROTOXICITY
    MIHATSCH, MJ
    THIEL, G
    SPICHTIN, HP
    OBERHOLZER, M
    OLIVIERI, V
    BREMER, I
    RYFFEL, B
    GUDAT, F
    ZOLLINGER, HU
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 114 (22) : 801 - 801
  • [44] Transdermal delivery of timolol by electroporation through human skin
    Denet, AR
    Préat, V
    JOURNAL OF CONTROLLED RELEASE, 2003, 88 (02) : 253 - 262
  • [45] Characteristic analysis of electroporation apparatus for transdermal drug delivery
    Bioelectromagnetics Lab. of Zhejiang, School of Medicine, Zhejiang University, Hangzhou 310058, China
    Yi Qi Yi Biao Xue Bao, 2008, 1 (16-20): : 16 - 20
  • [46] Lipid and electroosmosis enhanced transdermal delivery of insulin by electroporation
    Murthy, S. Narasimha
    Zhao, Ya-Li
    Marlan, Khin
    Hui, Sek Wen
    Kazim, A. Latif
    Sen, Arindam
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (09) : 2041 - 2050
  • [47] A practical assessment of transdermal drug delivery by skin electroporation
    Prausnitz, MR
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (01) : 61 - 76
  • [48] Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation
    Murthy, SN
    Zhao, YL
    Sen, A
    Hui, SW
    JOURNAL OF CONTROLLED RELEASE, 2004, 99 (03) : 393 - 402
  • [49] Controlled topical delivery of cyclosporin-A from nonionic liposomal formulations
    Waranuch, N
    Niemiec, SM
    Ramachandran, C
    Weiner, N
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 327 - 328
  • [50] Transdermal Delivery of Macromolecules Using Two-in-One Nanocomposite Device for Skin Electroporation
    Simon, Juliette
    Jouanmiqueou, Bastien
    Rols, Marie-Pierre
    Flahaut, Emmanuel
    Golzio, Muriel
    PHARMACEUTICS, 2021, 13 (11)